Human microglia are the CNS-resident myeloid immune cells, originating from embryonic yolk-sac–derived erythro-myeloid progenitors (EMPs). They contribute to brain development, immune surveillance, synaptic remodeling, homeostasis, and responses to injury. Microglial phenotypes are highly plastic and heterogeneous, varying with CNS region, developmental stage, age, microenvironment, and disease state.
Key Features
-
CNS-Resident Immune Cells : Commonly expressed microglial markers include P2RY12, TMEM119, CX3CR1, SALL1, and HEXB, although their expression can change with developmental and functional state.
-
Functional Plasticity : Microglia participate in phagocytosis, synaptic pruning and remodeling, neuroinflammatory signaling, clearance of cellular debris, and maintenance of neuronal and CNS homeostasis.
-
Relevance to Neurological Disease : Altered microglial states and functions are implicated in neurodegenerative diseases, neuroinflammation, brain injury, and other neurological disorders.
Usual Research Applications
-
Microglial Biology : Investigation of human microglial identity, phenotype, function, and cellular plasticity.
-
Neuroinflammation Research : Study of microglial inflammatory signaling, immune responses, and interactions with CNS cells.
-
Neurodegenerative Disease Research : Investigation of disease-associated microglial states and mechanisms relevant to Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.
-
Synapse–Microglia Interactions : Study of microglial contributions to synaptic remodeling and neuronal homeostasis.
-
Brain Injury and CNS Disease Modeling : Investigation of microglial responses to injury and disease-associated changes in human CNS models.
-
Drug Screening and Therapeutic Research : Evaluation of cellular responses to experimental compounds and potential modulators of microglial function.
-
Human Disease Modeling : Use of human primary and iPSC-derived microglia in neuronal co-cultures, brain organoids, and other human CNS model systems.